OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells
Ashraf S. Yousif, Larance Ronsard, Pankaj R. Shah, et al.
Immunity (2020) Vol. 54, Iss. 2, pp. 235-246.e5
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 476-488.e11
Open Access | Times Cited: 716

Interleukin-6: obstacles to targeting a complex cytokine in critical illness
Oliver J. McElvaney, Gerard F. Curley, Stefan Rose‐John, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 643-654
Open Access | Times Cited: 185

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183

Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
Konstantinos Arvanitakis, Triantafyllia Κoletsa, Ioannis Mitroulis, et al.
Cancers (2022) Vol. 14, Iss. 1, pp. 226-226
Open Access | Times Cited: 90

Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
Luke Y. C. Chen, Catherine M. Biggs, Shahin Jamal, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 5, pp. 100269-100269
Open Access | Times Cited: 63

Role of IL-6 in dendritic cell functions
Yu‐Dong Xu, Mi Cheng, Pan-Pan Shang, et al.
Journal of Leukocyte Biology (2021) Vol. 111, Iss. 3, pp. 695-709
Closed Access | Times Cited: 58

The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases
Minjun Wang, Hailing Zhang, Fei Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11

Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease
Tim Schumertl, Juliane Lokau, Stefan Rose‐John, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2021) Vol. 1869, Iss. 1, pp. 119143-119143
Open Access | Times Cited: 49

Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management
Eric J. Zhao, Catherine V Cheng, André Mattman, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 5, pp. e365-e375
Closed Access | Times Cited: 46

A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile
Wandong Hong, Xiaoying Zhou, Shengchun Jin, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 34

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, et al.
JCI Insight (2021) Vol. 6, Iss. 21
Open Access | Times Cited: 39

Diverse Control Mechanisms of the Interleukin-1 Cytokine Family
Charles L. Evavold, Jonathan C. Kagan
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20

CXCR1 drives the pathogenesis of EAE and ARDS via boosting dendritic cells-dependent inflammation
Wei Zhuang, Jinfeng Zhou, Lan Zhong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 11

An epitope-enriched immunogen expands responses to a conserved viral site
Timothy M. Caradonna, Larance Ronsard, Ashraf S. Yousif, et al.
Cell Reports (2022) Vol. 41, Iss. 6, pp. 111628-111628
Open Access | Times Cited: 15

A subcritical water extract of soil grown Zingiber officinale Roscoe: Comparative analysis of antioxidant and anti-inflammatory effects and evaluation of bioactive metabolites
Azraul Mumtazah Razak, Siti Nor Asyikin Zakaria, Nur Fathiah Abdul Sani, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8

The evolution of powerful yet perilous immune systems
Andrea L. Graham, Edward C. Schrom, C. Jessica E. Metcalf
Trends in Immunology (2021) Vol. 43, Iss. 2, pp. 117-131
Open Access | Times Cited: 19

Immunouniverse of SARS-CoV-2
Dennis Jiménez, Marbel Torres Arias
Immunological Medicine (2022) Vol. 45, Iss. 4, pp. 186-224
Open Access | Times Cited: 12

Mechanisms of antibody mediated immunity – Distinct in early life
Lucía Labeur-Iurman, James A. Harker
The International Journal of Biochemistry & Cell Biology (2024) Vol. 172, pp. 106588-106588
Open Access | Times Cited: 2

Gasdermin D kills bacteria
Abosede Salami, Sahana Bettadapura, Shanzhi Wang
Microbiological Research (2023) Vol. 272, pp. 127383-127383
Open Access | Times Cited: 6

CTRP4/interleukin-6 receptor signaling ameliorates autoimmune encephalomyelitis by suppressing Th17 cell differentiation
Lulu Cao, Jinhai Deng, Wei Chen, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 4
Open Access | Times Cited: 6

Markers of systemic inflammation are positively associated with influenza vaccine antibody responses with a possible role for ILT2(+)CD57(+) NK-cells
Émilie Picard, Sarah Armstrong, Melissa K. Andrew, et al.
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 9

PGE2 induced miR365/IL-6/STAT3 signaling mediates dendritic cell dysfunction in cancer
Vipul K. Pandey, Kavitha Premkumar, Priya Kundu, et al.
Life Sciences (2024) Vol. 350, pp. 122751-122751
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top